Poland· PL-100403775
Cilozek
A cilostazol product containing cilostazolum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cilostazol is registered in 8 of 19 countries.
Countries holding a registration under ATC B01AC23 (cilostazol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Cilostazol · ATC B01AC23
8 / 19 countries
- Czechiaprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cilostazol costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cilostazol · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- ES Spain$0.85
The record
At a glance
URPL (Poland)- Active substance
- Cilostazolum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B01AC23
- ATC class
- Cilostazol
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991369361
- gtin05909991369378
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
490 interactions on record for cilostazol.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cilostazol · interactions on record
490 records
- 147 severe
- 336 moderate
- 7 minor
Most severe, free to view
- OmeprazoleA02BC01severe
- LansoprazoleA02BC03severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cilostazol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCilostazol 100mg tabletsSigma Pharmaceuticals Plc
- CzechiaCILOSTAZOL STADASTADA Arzneimittel AG, Bad Vilbel
- SpainACETIVAL 100 MG COMPRIMIDOS EFGAtika Pharma S.L.
- United StatescilostazolAphena Pharma Solutions - Tennessee, LLC
- NorwayCilostazol alAliud Pharma
- SwedenCilostazol 2care4 100 mg Tablett2care4 ApS
- GermanyCilostazol AlAliud Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Лостразин, Тромбай
- Czechia · Cilostazol Stada, Noclaud
- Germany · Cilostazol Al, Cilostazol Stada
- Estonia · Cilostad, Cilostazol Stada
- Spain · Acetival, Cilostazol Aristo
- United Kingdom (Northern Ireland) · Cilostazol
- Greece · Cilos, Cilostazol Galenica
- Hungary · Antaclast, Cilostazol Teva
- Italy · Albaten, Cilostazolo Eg
- Lithuania · Dilsatan, Sollazon
- Latvia · Dilsatan, Sollazon
- Malta · Cilostazol, Cilostazol Libytec
- Portugal · Cilostazol Ferrer
- Romania · Dilvas, Velyn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af7e8e25-5e5c-44cc-be80-caefc7e0daef GET /v1/drugs/af7e8e25-5e5c-44cc-be80-caefc7e0daef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909991369361 ¦ Rp ¦ 127620\n28 tabl.\n05909991369378 ¦ Rp ¦ 127621\n56 tabl.",
"substance": "Cilostazolum 100 mg",
"common_name": "Cilostazolum",
"pl_product_id": "100403775",
"pozwolenie_nr": "100/18",
"auth_procedure": "IR",
"authorisation_validity": "2028-03-30"
}See everything about cilostazol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.